by Joel Rothman | Nov 16, 2009 | NutriSupLaw
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyper-linked line that warns consumers about the potential dangers of a drug....
by Joel Rothman | Nov 13, 2009 | NutriSupLaw
Ever since receiving FDA notices about their advertising generated from Google and similar searches, drugmakers have toned down their language and sought clarity on what is allowed. The discussion has ramifications for makers of nutritional supplements, because they...
by Joel Rothman | Nov 12, 2009 | NutriSupLaw
Should there be a language standard in Google ads for supplements? Drug marketers may adopt rules given the close scrutiny that the FDA is giving search-generated ads for pharmaceuticals. The Interactive Advertising Bureau is asking the feds to endorse the use of...
by Joel Rothman | Oct 11, 2009 | NutriSupLaw
The Web has erupted with news, opinion and practical guidance on the new FTC rules that apply to disclosures on blogger freebies. One commentary suggested that MIT graduates who wrote about fondly about their alma mater might subject the university to scrutiny. There...
by Joel Rothman | Oct 5, 2009 | NutriSupLaw
Three Americans won Nobel Prizes in physiology or medicine today for their research on telomeres, the endcaps of chromosomes that protect genetic material from being erased. Understanding how telomoeres work is enlightening scientists on aging and disease. Nutritional...
